5 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Aro Biotherapeutics Funding History

Since Aro Biotherapeutics was founded in 2017, it has participated in 5 rounds of funding. In total Aro Biotherapeutics has raised $151.0M. Aro Biotherapeutics' last funding round was on Nov 2023 for a total of $41.5M.

Aro Biotherapeutics Funding Rounds

Unlock 2 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Series B
Nov 2023
$41.5M
4
Johnson & Johnson Innovation,  Northpond Ventures,  Healthcap,  BVF Partners, L.P.
Series A
Jan 2021
$88M
8
Northpond Ventures,  Cowen Healthcare Investments,  HealthCap,  BVF Partners L.P,  Ridgeback Capital,  JJDC Inc,  BioMotiv, LLC,  Ionis Pharmaceuticals, Inc
Debt
Dec 2019
$5M
__
Debt
Mar 2019
$3.5M
__
Seed
Dec 2018
$13M
2
BioMotiv,  JJDC, Inc

Total Funding: $151M

Aro Biotherapeutics Investors

Unlock 10 more investors →

INVESTOR

ROUND

FUNDING DATE

Johnson & Johnson Innovation
Series B
Nov 2023
Northpond Ventures
Series B, Series A
Nov 2023, Jan 2021
Healthcap
Series B
Nov 2023
BVF Partners, L.P.
Series B
Nov 2023
Cowen Healthcare Investments
Series A
Jan 2021

Total Investors: 13

Aro Biotherapeutics has 13 investors, including Johnson & Johnson Innovation, Northpond Ventures and Healthcap. The latest investment occurred in Nov 2023.